NOVARTIS AG-SPONSORED ADR (NVS) Fundamental Analysis & Valuation

NYSE:NVS • US66987V1098

154.25 USD
-1.55 (-0.99%)
At close: Mar 12, 2026
153.77 USD
-0.48 (-0.31%)
After Hours: 3/12/2026, 6:40:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This NVS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

Taking everything into account, NVS scores 7 out of 10 in our fundamental rating. NVS was compared to 193 industry peers in the Pharmaceuticals industry. NVS gets an excellent profitability rating and is at the same time showing great financial health properties. NVS is not valued too expensively and it also shows a decent growth rate. NVS also has an excellent dividend rating. These ratings could make NVS a good candidate for dividend and quality investing.


Dividend Valuation Growth Profitability Health

9

1. NVS Profitability Analysis

1.1 Basic Checks

  • In the past year NVS was profitable.
  • NVS had a positive operating cash flow in the past year.
  • In the past 5 years NVS has always been profitable.
  • NVS had a positive operating cash flow in each of the past 5 years.
NVS Yearly Net Income VS EBIT VS OCF VS FCFNVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

1.2 Ratios

  • The Return On Assets of NVS (12.60%) is better than 93.26% of its industry peers.
  • Looking at the Return On Equity, with a value of 30.31%, NVS belongs to the top of the industry, outperforming 94.30% of the companies in the same industry.
  • The Return On Invested Capital of NVS (19.32%) is better than 95.85% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NVS is above the industry average of 13.09%.
  • The last Return On Invested Capital (19.32%) for NVS is above the 3 year average (17.15%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.6%
ROE 30.31%
ROIC 19.32%
ROA(3y)13.05%
ROA(5y)12.66%
ROE(3y)29.75%
ROE(5y)27.29%
ROIC(3y)17.15%
ROIC(5y)14%
NVS Yearly ROA, ROE, ROICNVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • With an excellent Profit Margin value of 24.83%, NVS belongs to the best of the industry, outperforming 92.75% of the companies in the same industry.
  • In the last couple of years the Profit Margin of NVS has grown nicely.
  • The Operating Margin of NVS (33.18%) is better than 94.82% of its industry peers.
  • In the last couple of years the Operating Margin of NVS has grown nicely.
  • With an excellent Gross Margin value of 75.82%, NVS belongs to the best of the industry, outperforming 82.38% of the companies in the same industry.
  • In the last couple of years the Gross Margin of NVS has remained more or less at the same level.
Industry RankSector Rank
OM 33.18%
PM (TTM) 24.83%
GM 75.82%
OM growth 3Y12.14%
OM growth 5Y6.09%
PM growth 3Y15.69%
PM growth 5Y8.94%
GM growth 3Y0.74%
GM growth 5Y1.28%
NVS Yearly Profit, Operating, Gross MarginsNVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. NVS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so NVS is creating value.
  • NVS has less shares outstanding than it did 1 year ago.
  • NVS has less shares outstanding than it did 5 years ago.
  • NVS has a worse debt/assets ratio than last year.
NVS Yearly Shares OutstandingNVS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
NVS Yearly Total Debt VS Total AssetsNVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B

2.2 Solvency

  • NVS has an Altman-Z score of 4.44. This indicates that NVS is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.44, NVS is in the better half of the industry, outperforming 73.58% of the companies in the same industry.
  • NVS has a debt to FCF ratio of 2.32. This is a good value and a sign of high solvency as NVS would need 2.32 years to pay back of all of its debts.
  • NVS has a Debt to FCF ratio of 2.32. This is amongst the best in the industry. NVS outperforms 94.30% of its industry peers.
  • A Debt/Equity ratio of 0.64 indicates that NVS is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.64, NVS is doing worse than 65.80% of the companies in the same industry.
  • Although NVS's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 2.32
Altman-Z 4.44
ROIC/WACC3.83
WACC5.04%
NVS Yearly LT Debt VS Equity VS FCFNVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 1.12 indicates that NVS should not have too much problems paying its short term obligations.
  • NVS has a worse Current ratio (1.12) than 79.79% of its industry peers.
  • A Quick Ratio of 0.89 indicates that NVS may have some problems paying its short term obligations.
  • The Quick ratio of NVS (0.89) is worse than 78.24% of its industry peers.
  • The current and quick ratio evaluation for NVS is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.89
NVS Yearly Current Assets VS Current LiabilitesNVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. NVS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 14.98% over the past year.
  • The Earnings Per Share has been growing by 9.21% on average over the past years. This is quite good.
  • The Revenue has grown by 8.91% in the past year. This is quite good.
  • NVS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.45% yearly.
EPS 1Y (TTM)14.98%
EPS 3Y13.63%
EPS 5Y9.21%
EPS Q2Q%2.53%
Revenue 1Y (TTM)8.91%
Revenue growth 3Y9.1%
Revenue growth 5Y2.45%
Sales Q2Q%1.39%

3.2 Future

  • Based on estimates for the next years, NVS will show a small growth in Earnings Per Share. The EPS will grow by 7.48% on average per year.
  • NVS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.99% yearly.
EPS Next Y0.69%
EPS Next 2Y4.79%
EPS Next 3Y5.96%
EPS Next 5Y7.48%
Revenue Next Year2.75%
Revenue Next 2Y3.82%
Revenue Next 3Y4.46%
Revenue Next 5Y4.99%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NVS Yearly Revenue VS EstimatesNVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
NVS Yearly EPS VS EstimatesNVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. NVS Valuation Analysis

4.1 Price/Earnings Ratio

  • NVS is valuated rather expensively with a Price/Earnings ratio of 17.08.
  • 85.49% of the companies in the same industry are more expensive than NVS, based on the Price/Earnings ratio.
  • NVS is valuated rather cheaply when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
  • NVS is valuated correctly with a Price/Forward Earnings ratio of 16.97.
  • 82.38% of the companies in the same industry are more expensive than NVS, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.27, NVS is valued a bit cheaper.
Industry RankSector Rank
PE 17.08
Fwd PE 16.97
NVS Price Earnings VS Forward Price EarningsNVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NVS is valued cheaply inside the industry as 83.94% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, NVS is valued cheaply inside the industry as 84.97% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 19.42
EV/EBITDA 13.43
NVS Per share dataNVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NVS does not grow enough to justify the current Price/Earnings ratio.
  • NVS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)24.59
PEG (5Y)1.85
EPS Next 2Y4.79%
EPS Next 3Y5.96%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. NVS Dividend Analysis

5.1 Amount

  • NVS has a Yearly Dividend Yield of 2.96%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.71, NVS pays a better dividend. On top of this NVS pays more dividend than 94.30% of the companies listed in the same industry.
  • NVS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.96%

5.2 History

  • The dividend of NVS has a limited annual growth rate of 5.38%.
  • NVS has paid a dividend for at least 10 years, which is a reliable track record.
  • As NVS did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)5.38%
Div Incr Years5
Div Non Decr Years5
NVS Yearly Dividends per shareNVS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8 10

5.3 Sustainability

  • 55.91% of the earnings are spent on dividend by NVS. This is a bit on the high side, but may be sustainable.
  • NVS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP55.91%
EPS Next 2Y4.79%
EPS Next 3Y5.96%
NVS Yearly Income VS Free CF VS DividendNVS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B
NVS Dividend Payout.NVS Dividend Payout, showing the Payout Ratio.NVS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NVS Fundamentals: All Metrics, Ratios and Statistics

NOVARTIS AG-SPONSORED ADR

NYSE:NVS (3/12/2026, 6:40:00 PM)

After market: 153.77 -0.48 (-0.31%)

154.25

-1.55 (-0.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-04
Earnings (Next)04-27
Inst Owners41.7%
Inst Owner Change0.15%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap295.97B
Revenue(TTM)56.33B
Net Income(TTM)13.98B
Analysts70.59
Price Target156 (1.13%)
Short Float %0.44%
Short Ratio3.55
Dividend
Industry RankSector Rank
Dividend Yield 2.96%
Yearly Dividend4.02
Dividend Growth(5Y)5.38%
DP55.91%
Div Incr Years5
Div Non Decr Years5
Ex-Date03-11
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.14%
Min EPS beat(2)-2.1%
Max EPS beat(2)-0.17%
EPS beat(4)2
Avg EPS beat(4)1.23%
Min EPS beat(4)-2.1%
Max EPS beat(4)6.59%
EPS beat(8)6
Avg EPS beat(8)2.93%
EPS beat(12)9
Avg EPS beat(12)2.91%
EPS beat(16)11
Avg EPS beat(16)2.66%
Revenue beat(2)0
Avg Revenue beat(2)-3.85%
Min Revenue beat(2)-4.89%
Max Revenue beat(2)-2.82%
Revenue beat(4)0
Avg Revenue beat(4)-2.92%
Min Revenue beat(4)-4.89%
Max Revenue beat(4)-1.13%
Revenue beat(8)2
Avg Revenue beat(8)-1.5%
Revenue beat(12)3
Avg Revenue beat(12)-2.67%
Revenue beat(16)4
Avg Revenue beat(16)-0.2%
PT rev (1m)4.11%
PT rev (3m)15.52%
EPS NQ rev (1m)-5.37%
EPS NQ rev (3m)-8.29%
EPS NY rev (1m)-3.05%
EPS NY rev (3m)-4.01%
Revenue NQ rev (1m)-1.24%
Revenue NQ rev (3m)-3.1%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 17.08
Fwd PE 16.97
P/S 5.25
P/FCF 19.42
P/OCF 15.46
P/B 6.42
P/tB N/A
EV/EBITDA 13.43
EPS(TTM)9.03
EY5.85%
EPS(NY)9.09
Fwd EY5.89%
FCF(TTM)7.94
FCFY5.15%
OCF(TTM)9.98
OCFY6.47%
SpS29.36
BVpS24.04
TBVpS-4.61
PEG (NY)24.59
PEG (5Y)1.85
Graham Number69.89
Profitability
Industry RankSector Rank
ROA 12.6%
ROE 30.31%
ROCE 22.34%
ROIC 19.32%
ROICexc 22.42%
ROICexgc 94.51%
OM 33.18%
PM (TTM) 24.83%
GM 75.82%
FCFM 27.06%
ROA(3y)13.05%
ROA(5y)12.66%
ROE(3y)29.75%
ROE(5y)27.29%
ROIC(3y)17.15%
ROIC(5y)14%
ROICexc(3y)20.47%
ROICexc(5y)17.14%
ROICexgc(3y)94.66%
ROICexgc(5y)84.88%
ROCE(3y)20.57%
ROCE(5y)16.8%
ROICexgc growth 3Y10.97%
ROICexgc growth 5Y16.26%
ROICexc growth 3Y23.26%
ROICexc growth 5Y13.82%
OM growth 3Y12.14%
OM growth 5Y6.09%
PM growth 3Y15.69%
PM growth 5Y8.94%
GM growth 3Y0.74%
GM growth 5Y1.28%
F-Score8
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 2.32
Debt/EBITDA 1.23
Cap/Depr 73.24%
Cap/Sales 6.92%
Interest Coverage 19.05
Cash Conversion 79.71%
Profit Quality 109.01%
Current Ratio 1.12
Quick Ratio 0.89
Altman-Z 4.44
F-Score8
WACC5.04%
ROIC/WACC3.83
Cap/Depr(3y)63.14%
Cap/Depr(5y)55.05%
Cap/Sales(3y)6.73%
Cap/Sales(5y)6.62%
Profit Quality(3y)101.15%
Profit Quality(5y)104.02%
High Growth Momentum
Growth
EPS 1Y (TTM)14.98%
EPS 3Y13.63%
EPS 5Y9.21%
EPS Q2Q%2.53%
EPS Next Y0.69%
EPS Next 2Y4.79%
EPS Next 3Y5.96%
EPS Next 5Y7.48%
Revenue 1Y (TTM)8.91%
Revenue growth 3Y9.1%
Revenue growth 5Y2.45%
Sales Q2Q%1.39%
Revenue Next Year2.75%
Revenue Next 2Y3.82%
Revenue Next 3Y4.46%
Revenue Next 5Y4.99%
EBIT growth 1Y14.46%
EBIT growth 3Y22.35%
EBIT growth 5Y8.7%
EBIT Next Year11.91%
EBIT Next 3Y9.08%
EBIT Next 5Y8.66%
FCF growth 1Y10.42%
FCF growth 3Y9.64%
FCF growth 5Y6.62%
OCF growth 1Y8.66%
OCF growth 3Y10.38%
OCF growth 5Y7%

NOVARTIS AG-SPONSORED ADR / NVS FAQ

What is the ChartMill fundamental rating of NOVARTIS AG-SPONSORED ADR (NVS) stock?

ChartMill assigns a fundamental rating of 7 / 10 to NVS.


What is the valuation status for NVS stock?

ChartMill assigns a valuation rating of 6 / 10 to NOVARTIS AG-SPONSORED ADR (NVS). This can be considered as Fairly Valued.


How profitable is NOVARTIS AG-SPONSORED ADR (NVS) stock?

NOVARTIS AG-SPONSORED ADR (NVS) has a profitability rating of 9 / 10.


How financially healthy is NOVARTIS AG-SPONSORED ADR?

The financial health rating of NOVARTIS AG-SPONSORED ADR (NVS) is 7 / 10.


Is the dividend of NOVARTIS AG-SPONSORED ADR sustainable?

The dividend rating of NOVARTIS AG-SPONSORED ADR (NVS) is 7 / 10 and the dividend payout ratio is 55.91%.